3 Reasons I’m Buying WELL Health Stock Today

With WELL Health consistently growing its sales and profitability while continuing to lose value, it’s one of the best stocks to buy now.

| More on:

As many savvy investors know, these temporarily volatile and highly uncertain market environments can make for great buying opportunities for investors. Plenty of high-quality stocks with years of growth potential, such as WELL Health Technologies (TSX:WELL) stock, trade unbelievably cheap.

And while it can be difficult to put your hard-earned money to work when there is so much uncertainty and talks of a recession on the horizon, being able to see the bigger picture and potential these stocks have to rally when markets do eventually turn around is crucial, in order to take advantage of the opportunity.

One of the biggest problems with this environment, though, is that with so many stocks trading at compelling valuations, investors can be overwhelmed with choice, making it difficult to decide exactly which stocks are some of the best to buy.

So here’s why WELL Health is one of the best stocks to consider now, and three reasons why I continue to build my position in the high-potential healthcare tech stock.

WELL Health stock continues to grow rapidly

While other businesses are seeing their revenue impacted in this economic environment, WELL continues to grow at an impressive rate.

Of course, it’s no longer making the same number of acquisitions each year as it did at the height of the pandemic, but it continues to see higher patient visits and more organic growth, which is not necessarily surprising, given the convenience it offers patients as well as the essential nature of the healthcare industry.

And this continued growth is now leading to more and more profitability for the small-cap stock. In its most recent earnings report, for the third quarter of 2023, WELL once again beat sales estimates.

Canadian Patient Services revenue of $57.8 million was up 27% year over year. U.S. Patient Services revenue of $130.7 million was up 52% year over year. And WELL’s total revenue is now 40% higher than it was last year and up 20% quarter over quarter.

Furthermore, WELL Health stock also increased its guidance for 2023 and introduced 2024 guidance, which points to another 17.5% expected increase in sales over the next 12 months.

The healthcare sector is essential to our economy

While some growth stocks may have more risk in this environment due to the impacts they face as the economy worsens, WELL is in a much better position since the healthcare sector is essential.

This not only means there is less risk that WELL could see a significant impact on its operations, but it also means that it could continue to see rapid growth in the near term while many others struggle.

This is one of the main reasons why I continue to build my position in WELL Health despite growing uncertainty in the stock market.

WELL Health stock is trading significantly undervalued

Finally, the third and most important reason why I’m looking to buy WELL Health stock now is that it’s trading unbelievably cheap. With WELL trading at around $3.80 a share, it’s over 35% off its 52-week high and trades at just 1 times its forward sales.

For comparison, its one- and three-year average forward price-to-sales ratios are 1.4 and 3.3 times, respectively. That’s not all, though.

With WELL now focusing on growing its profitability as well as its sales, the stock trades at a forward price-to-earnings ratio of just 13.3 times and a forward enterprise value-to-earnings before interest, taxes, depreciation and amortization (EV/EBITDA) ratio of just 10.9 times. Both are extremely cheap valuations for a small-cap tech stock with significant long-term growth potential.

And although you should never base your investment solely on what analysts think, it can be helpful to check in on how they view the company. And unsurprisingly, a high-quality stock like WELL has a tonne of analyst love.

Right now, of the eight analysts that cover WELL, there are seven buy ratings and one sell rating. Furthermore, its average analyst target price of $8.36 is a more than 120% premium to where WELL Health stock trades today.

So if you’re looking for a high-potential growth stock to buy now, WELL Health is one of the cheapest stocks on the market today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Daniel Da Costa has positions in Well Health Technologies. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

A Canada Pension Plan Statement of Contributions with a 100 dollar banknote and dollar coins.
Dividend Stocks

3 Compelling Reasons to Delay Taking CPP Benefits Until Age 70

You don't need to take CPP early if you are receiving large dividend payments from Fortis Inc (TSX:FTS) stock.

Read more »

A worker overlooks an oil refinery plant.
Dividend Stocks

Better Dividend Stock: TC Energy vs. Enbridge

TC Energy and Enbridge have enjoyed big rallies in 2024. Is one stock still cheap?

Read more »

Trans Alaska Pipeline with Autumn Colors
Energy Stocks

Is South Bow Stock a Buy After its Split From TC Energy?

Let’s see if South Bow stock's current valuation makes sense.

Read more »

Concept of multiple streams of income
Dividend Stocks

Got $10,000? Buy This Dividend Stock for $4,992.40 in Total Passive Income

Want almost $5,000 in annual passive income? Then you need a company bound for even more growth, with a dividend…

Read more »

ETF stands for Exchange Traded Fund
Investing

Passive Income Investors: This TSX Fund Has a 7.6% Yield With Monthly Payouts

Here's all you need to know about the Canoe EIT Income Fund (TSX:EIT.UN)

Read more »

stock research, analyze data
Tech Stocks

Apple vs. Shopify: Which Stock Is the Better Buy for the Next 3 Years?

Apple (NASDAQ:AAPL) and Shopify (TSX:SHOP) are great tech titans, but they're ending the year with huge momentum.

Read more »

Investor reading the newspaper
Dividend Stocks

Emerging Investment Trends to Watch for in 2025

Canadians must watch out for and be guided by emerging investment trends to ensure financial success in 2025.

Read more »

RRSP Canadian Registered Retirement Savings Plan concept
Dividend Stocks

Watch Out! This is the Maximum Canadians Can Contribute to Their RRSP

We often discuss the maximum TFSA amount, but did you know there's a max for the RRSP as well? Here's…

Read more »